Announced
Completed
Otium Capital led a €16m Series A round in BeFC Bioenzymatic.
Synopsis
Otium Capital, an investment company, led a €16m Series A round in BeFC Bioenzymatic, a renewable energy semiconductor manufacturing, with participation from Demeter, BNP Paribas Développement and Supernova Invest.
Show Details & Financials
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.